STOCK TITAN

Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Shockwave Medical, Inc. (SWAV) will participate in the 23rd Annual Needham Virtual Healthcare Conference from April 8 to April 11, 2024. The company's management will have a live fireside chat on April 9, 2024, at 8:45 a.m. Eastern Time.
Positive
  • None.
Negative
  • None.

SANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that the company will be participating in the 23rd Annual Needham Virtual Healthcare Conference, which is being held virtually from Monday, April 8 to Thursday, April 11, 2024.

Shockwave’s management is scheduled for a live fireside chat on Tuesday, April 9, 2024, at 8:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at: https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.
Shockwave Medical is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by safely using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Shockwave has also recently acquired the Reducer, which is under clinical investigation in the United States and is CE Marked in Europe. By redistributing blood flow within the heart, the Reducer is designed to provide relief to the millions of patients worldwide suffering from refractory angina. Learn more at www.shockwavemedical.com.

Media Contact:
Scott Shadiow
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com


FAQ

When will Shockwave Medical (SWAV) participate in the 23rd Annual Needham Virtual Healthcare Conference?

Shockwave Medical (SWAV) will participate in the 23rd Annual Needham Virtual Healthcare Conference from April 8 to April 11, 2024.

When is the live fireside chat scheduled for Shockwave Medical's (SWAV) management?

The live fireside chat for Shockwave Medical's (SWAV) management is scheduled for April 9, 2024, at 8:45 a.m. Eastern Time.

Where can interested parties access the live and archived webcast of the event?

Interested parties can access the live and archived webcast of the event on the 'Investors' section of Shockwave Medical's (SWAV) website at: https://ir.shockwavemedical.com.

Shockwave Medical, Inc.

NASDAQ:SWAV

SWAV Rankings

SWAV Latest News

SWAV Stock Data

12.38B
36.82M
1.27%
95.6%
5.43%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SANTA CLARA

About SWAV

shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen